Figure 5.

Effect of anacetrapib, atorvastatin, and their combination on endothelial-vasoprotective properties of HDL, in particular pro-inflammatory cytokine-induced VCAM-1 expression (A) and apoptotic cell death (B). Data are presented as means ± SD.